Literature DB >> 10964754

STAT5-Dependent CyclinD1 and Bcl-xL expression in Bcr-Abl-transformed cells.

R P de Groot1, J A Raaijmakers, J W Lammers, L Koenderman.   

Abstract

Signal transducers and activators of transcription (STATs) are a family of transcription factors that were originally identified as mediators of cytokine-induced gene expression. We and others have recently shown that STAT5 also plays a major role in cellular transformation by the Bcr-Abl oncogene. Here we show that the antiapoptotic bcl-xL gene product and the cell cycle regulator cyclin D1 are targets of STAT5 in Bcr-Abl-transformed cells. In the CML cell line K562 and in BaF3 cells ectopically expressing Bcr-Abl, both the cyclin D1 and bcl-x promoters are highly active. The activity of these promoters can be strongly repressed by cotransfection of a dominant negative (DN) mutant of STAT5. Moreover, the cyclin D1 and bcl-x promoters contain STAT binding sites to which STAT5 constitutively binds in Bcr-Abl transformed cells. These results suggest that STAT5 contributes to transformation by Bcr-Abl by induction of cyclin D1 and bcl-xL expression. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10964754     DOI: 10.1006/mcbr.2000.0231

Source DB:  PubMed          Journal:  Mol Cell Biol Res Commun        ISSN: 1522-4724


  40 in total

Review 1.  Molecular pathways to CML stem cells.

Authors:  Kristen N Rice; Catriona H M Jamieson
Journal:  Int J Hematol       Date:  2010-06-10       Impact factor: 2.490

2.  Expression of phosphorylated Stat5 predicts expression of cyclin D1 and correlates with poor prognosis of colonic adenocarcinoma.

Authors:  Yinling Mao; Zhiwei Li; Changjie Lou; Yanqiao Zhang
Journal:  Int J Colorectal Dis       Date:  2010-11-16       Impact factor: 2.571

3.  Novel iodoacetamido benzoheterocyclic derivatives with potent antileukemic activity are inhibitors of STAT5 phosphorylation.

Authors:  Romeo Romagnoli; Pier Giovanni Baraldi; Filippo Prencipe; Carlota Lopez-Cara; Riccardo Rondanin; Daniele Simoni; Ernest Hamel; Stefania Grimaudo; Rosaria Maria Pipitone; Maria Meli; Manlio Tolomeo
Journal:  Eur J Med Chem       Date:  2015-11-27       Impact factor: 6.514

4.  Bcr-Abl stabilizes beta-catenin in chronic myeloid leukemia through its tyrosine phosphorylation.

Authors:  Addolorata Maria Luce Coluccia; Angelo Vacca; Mireia Duñach; Luca Mologni; Sara Redaelli; Victor H Bustos; Daniela Benati; Lorenzo A Pinna; Carlo Gambacorti-Passerini
Journal:  EMBO J       Date:  2007-02-22       Impact factor: 11.598

5.  Targeted blockage of signal transducer and activator of transcription 5 signaling pathway with decoy oligodeoxynucleotides suppresses leukemic K562 cell growth.

Authors:  Xiaozhong Wang; Jianming Zeng; Mei Shi; Shiqiao Zhao; Weijun Bai; Weixi Cao; Zhiguang Tu; Zonggan Huang; Wenli Feng
Journal:  DNA Cell Biol       Date:  2010-11-22       Impact factor: 3.311

Review 6.  Targeting signal transducer and activator of transcription signaling pathway in leukemias.

Authors:  Mustafa Benekli; Heinz Baumann; Meir Wetzler
Journal:  J Clin Oncol       Date:  2009-08-10       Impact factor: 44.544

7.  Monomethylarsonous acid (MMA+3) Inhibits IL-7 Signaling in Mouse Pre-B Cells.

Authors:  Peace C Ezeh; Huan Xu; Fredine T Lauer; Ke Jian Liu; Laurie G Hudson; Scott W Burchiel
Journal:  Toxicol Sci       Date:  2015-10-30       Impact factor: 4.849

8.  Environmentally relevant concentrations of arsenite and monomethylarsonous acid inhibit IL-7/STAT5 cytokine signaling pathways in mouse CD3+CD4-CD8- double negative thymus cells.

Authors:  Huan Xu; Fredine T Lauer; Ke Jian Liu; Laurie G Hudson; Scott W Burchiel
Journal:  Toxicol Lett       Date:  2016-02-24       Impact factor: 4.372

9.  Ubiquitin-mediated interaction of p210 BCR/ABL with β-catenin supports disease progression in a murine model for chronic myelogenous leukemia.

Authors:  Ru Chen; Tinghui Hu; Gwendolyn M Mahon; Ilona Tala; Nicole L Pannucci; Harvey L Ozer; Ian P Whitehead
Journal:  Blood       Date:  2013-08-15       Impact factor: 22.113

10.  A novel role for signal transducer and activator of transcription 5b (STAT5b) in beta1-integrin-mediated human breast cancer cell migration.

Authors:  Teresa M Bernaciak; Jessica Zareno; J Thomas Parsons; Corinne M Silva
Journal:  Breast Cancer Res       Date:  2009-07-24       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.